MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1045.06%
Quick Ratio
1045.06%
Cash Ratio
329.70%
Debt to Asset Ratio
8.46%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term marketable securities
    • Long-term marketable securities
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
272,589
157,522
112,825
298,927
Short-term marketable securities
556,366
513,679
526,563
487,967
Prepaid expenses and other current assets
19,653
18,346
21,366
15,761
Contract assets
15,417
6,560
5,973
-
Total current assets
864,025
696,107
666,727
802,655
Restricted cash
1,281
1,281
1,015
805
Long-term marketable securities
413,934
301,713
410,297
349,960
Total property and equipment
23,913
23,579
22,473
21,862
Less accumulated depreciation and amortization
15,633
14,945
14,256
13,690
Property and equipment, net
8,280
8,634
8,217
8,172
Right-of-use assets
22,179
22,613
23,068
23,544
Total assets
1,309,699
1,030,348
1,109,324
1,185,136
Accounts payable
30,508
20,736
17,584
18,433
Accrued liabilities
50,979
43,745
40,892
45,258
Contract liabilities, current
-
-
-
490
Operating lease liabilities, current
1,190
350
339
328
Total current liabilities
82,677
64,831
58,815
64,509
Long-term contract liabilities
-
-
-
1,676
Long-term operating lease liabilities
28,117
28,250
27,575
26,917
Total liabilities
110,794
93,081
86,390
93,102
Common stock, 0.0001 par value, 300,000,000 shares authorized as of june 30, 2026 and december 31, 2025 96,375,637 and 87,796,561 shares issued and outstanding as of june 30, 2026 and december 31, 2025
10
9
9
9
Additional paid-in capital
2,148,095
1,772,830
1,757,197
1,743,239
Accumulated other comprehensive (loss) income
-1,670
-494
2,267
2,052
Accumulated deficit
-947,530
-835,078
-736,539
-653,266
Total stockholders equity
1,198,905
937,267
1,022,934
1,092,034
Total liabilities and stockholders equity
1,309,699
1,030,348
1,109,324
1,185,136
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term marketablesecurities$556,366K (0.23%↑ Y/Y)Cash and cashequivalents$272,589K (137.77%↑ Y/Y)Prepaid expenses andother current assets$19,653K (23.88%↑ Y/Y)Contract assets$15,417K Total property andequipment$23,913K (9.56%↑ Y/Y)Total current assets$864,025K (26.02%↑ Y/Y)Long-term marketablesecurities$413,934K (28.50%↑ Y/Y)Right-of-use assets$22,179K (-7.25%↓ Y/Y)Property and equipment,net$8,280K (-6.11%↓ Y/Y)Restricted cash$1,281K (59.13%↑ Y/Y)Less accumulateddepreciation and...$15,633K (20.19%↑ Y/Y)Total assets$1,309,699K (25.78%↑ Y/Y)Total liabilities andstockholders equity$1,309,699K (25.78%↑ Y/Y)Total stockholdersequity$1,198,905K (24.93%↑ Y/Y)Total liabilities$110,794K (35.75%↑ Y/Y)Accumulated deficit-$947,530K (-22.66%↓ Y/Y)Accumulated othercomprehensive (loss) income-$1,670K (-209.80%↓ Y/Y)Additional paid-in capital$2,148,095K (24.12%↑ Y/Y)Total currentliabilities$82,677K (49.40%↑ Y/Y)Long-term operating leaseliabilities$28,117K (6.99%↑ Y/Y)Common stock, 0.0001par value,...$10K (11.11%↑ Y/Y)Accrued liabilities$50,979K (35.04%↑ Y/Y)Accounts payable$30,508K (76.65%↑ Y/Y)Operating leaseliabilities, current$1,190K (274.21%↑ Y/Y)

IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences, Inc. (IDYA)